ROCK-IN-D2 | CAS#1219721-78-4 | ROCK inhibitor

MedKoo Cat#: 562375 | Name: ROCK-IN-D2

Description:

WARNING: This product is for research use only, not for human or veterinary use.

ROCK-IN-D2 is a potent and selective ROCK inhibitor.

Chemical Structure

ROCK-IN-D2

CAS#1219721-78-4

Theoretical Analysis

MedKoo Cat#: 562375

Name: ROCK-IN-D2

CAS#: 1219721-78-4

Chemical Formula: C22H28N6O

Exact Mass: 392.2325

Molecular Weight: 392.50

Elemental Analysis: C, 67.32; H, 7.19; N, 21.41; O, 4.08

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.

Bulk Inquiry

Related CAS #

No Data

Synonym

ROCK-IN-D2; ROCK IN D2; ROCKIND2; ROCK inhibitor D2; ROCK-inhibitor-D2;

IUPAC/Chemical Name

1-benzyl-3-(2-((2-(dimethylamino)ethyl)(methyl)amino)-4-(1H-pyrazol-4-yl)phenyl)urea

InChi Key

UBZZFFAVFOEUFI-UHFFFAOYSA-N

InChi Code

InChI=1S/C22H28N6O/c1-27(2)11-12-28(3)21-13-18(19-15-24-25-16-19)9-10-20(21)26-22(29)23-14-17-7-5-4-6-8-17/h4-10,13,15-16H,11-12,14H2,1-3H3,(H,24,25)(H2,23,26,29)

SMILES Code

O=C(NC1=C(N(CCN(C)C)C)C=C(C2=CNN=C2)C=C1)NCC3=CC=CC=C3

Appearance

Solid powder

Purity

>98% (or refer to the Certificate of Analysis)

Shipping Condition

Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition

Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility

Soluble in DMSO

Shelf Life

>2 years if stored properly

Drug Formulation

This drug may be formulated in DMSO

Stock Solution Storage

0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code

2934.99.9001

More Info

Instruction

View handling instruction

Preparing Stock Solutions

The following data is based on the product molecular weight 392.50 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Concentration / Solvent Volume / Mass	1 mg	5 mg	10 mg
1 mM	1.15 mL	5.76 mL	11.51 mL
5 mM	0.23 mL	1.15 mL	2.3 mL
10 mM	0.12 mL	0.58 mL	1.15 mL
50 mM	0.02 mL	0.12 mL	0.23 mL

1: Foti RS, Pearson JT, Wong SL, Zalikowski JA, Boudreaux MD, Prokop SP, Davis JA, Banfield C, Emery MG, Rock DA, Wahlstrom JL, Wienkers LC, Amore BM. Predicting the drug interaction potential of AMG 853, a dual antagonist of the D-prostanoid and chemoattractant receptor-homologous molecule expressed on T helper 2 cells receptors. Drug Metab Dispos. 2012 Dec;40(12):2239-49. doi: 10.1124/dmd.112.047928. Epub 2012 Aug 28. PubMed PMID: 22930276. 2: Choi HJ, Han JS. Overexpression of phospholipase D enhances Bcl-2 expression by activating STAT3 through independent activation of ERK and p38MAPK in HeLa cells. Biochim Biophys Acta. 2012 Jun;1823(6):1082-91. doi: 10.1016/j.bbamcr.2012.03.015. Epub 2012 Apr 5. PubMed PMID: 22504301. 3: Phulwani NK, Feinstein DL, Gavrilyuk V, Akar C, Kielian T. 15-deoxy-Delta12,14-prostaglandin J2 (15d-PGJ2) and ciglitazone modulate Staphylococcus aureus-dependent astrocyte activation primarily through a PPAR-gamma-independent pathway. J Neurochem. 2006 Dec;99(5):1389-1402. PubMed PMID: 17074064; PubMed Central PMCID: PMC2423669. 4: Drew PD, Storer PD, Xu J, Chavis JA. Hormone regulation of microglial cell activation: relevance to multiple sclerosis. Brain Res Brain Res Rev. 2005 Apr;48(2):322-7. Epub 2005 Jan 19. Review. PubMed PMID: 15850670; PubMed Central PMCID: PMC2819756. 5: Kielian T, McMahon M, Bearden ED, Baldwin AC, Drew PD, Esen N. S. aureus-dependent microglial activation is selectively attenuated by the cyclopentenone prostaglandin 15-deoxy-Delta12,14- prostaglandin J2 (15d-PGJ2). J Neurochem. 2004 Sep;90(5):1163-72. PubMed PMID: 15312171; PubMed Central PMCID: PMC2366814. 6: Hashimoto T, Ohata H, Momose K. Itch-scratch responses induced by lysophosphatidic acid in mice. Pharmacology. 2004 Sep;72(1):51-6. PubMed PMID: 15292655. 7: Garg TK, Chang JY. Oxidative stress causes ERK phosphorylation and cell death in cultured retinal pigment epithelium: prevention of cell death by AG126 and 15-deoxy-delta 12, 14-PGJ2. BMC Ophthalmol. 2003 Mar 21;3:5. PubMed PMID: 12659653; PubMed Central PMCID: PMC153521. 8: Lai JM, Wu S, Huang DY, Chang ZF. Cytosolic retention of phosphorylated extracellular signal-regulated kinase and a Rho-associated kinase-mediated signal impair expression of p21(Cip1/Waf1) in phorbol 12-myristate-13- acetate-induced apoptotic cells. Mol Cell Biol. 2002 Nov;22(21):7581-92. PubMed PMID: 12370305; PubMed Central PMCID: PMC135659. 9: Holmström C, James S, Egan S, Kjelleberg S. Inhibition of common fouling organisms by marine bacterial isolates ith special reference to the role of pigmented bacteria. Biofouling. 1996;10(1-3):251-9. doi: 10.1080/08927019609386284. PubMed PMID: 22115116. 10: Sallee FR, Sethuraman G, Rock CM. Effects of pimozide on cognition in children with Tourette syndrome: interaction with comorbid attention deficit hyperactivity disorder. Acta Psychiatr Scand. 1994 Jul;90(1):4-9. PubMed PMID: 7976448.